– USA, OH – Navidea Biopharmaceuticals, Inc. (NYSE: NAVB), a company focused on the development of precision immuno-diagnostic agents and immuno-therapeutics, today announced the appointment of Malcolm Witter to its Board of Directors.
“We are fortunate to have Malcolm Witter join Navidea’s Board of Directors. Malcolm’s expertise in M&A, corporate finance, and corporate governance better equip the Company as it moves into the new year. We look forward to Malcolm’s input and engagement in guiding Navidea toward future development and success.” said CEO, Jed Latkin.
About Max Witter
Mr. Witter brings decades of financial and corporate governance experience to the board. He currently serves as a corporate development leader for USI Insurance Services and is responsible for acquiring independent insurance agencies. Before USI, Mr. Witter held roles at multiple financial institutions including Bear Stearns, EF Hutton, and Dean Witter.
Mr. Witter received his MBA from the Stanford Graduate School of Business and he also serves as the President of the Dean Witter Foundation.
About Navidea
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development of precision immunodiagnostic agents and immunotherapeutics. Navidea is developing multiple precision-targeted products based on its Manocept platform to enhance patient care by identifying the sites and pathways of disease and enable better diagnostic accuracy, clinical decision-making, and targeted treatment. Navidea’s Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. The Manocept platform serves as the molecular backbone of Tc99m tilmanocept, the first product developed and commercialized by Navidea based on the platform. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel products and advancing the Company’s pipeline through global partnering and commercialization efforts.
For more information: https://www.navidea.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
